BC
Brandon Couillard Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
72
Avg Return
Past Year
Past Year
2.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
46.2%
Neutral
53.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Diagnostics & Research
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $90 |
13%
upside
| 1 | – |
–
| 5 Mar ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $215 |
3%
upside
| 1 | – |
–
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $165 |
35%
upside
| 1 | -0.14% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $180 |
37%
upside
| 1 | -1.2% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $21 |
2%
downside
| 1 | – |
–
| 25 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $6 |
18%
upside
| 1 | – |
–
| 24 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $125 |
38%
upside
| 1 | +20% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $14 |
64%
upside
| 1 | -20% |
0
%
| 13 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $355 |
8%
upside
| 1 | -20% |
–
| 11 Feb ‘26 2 months ago |
|
|
|
Overweight
Upgraded
| $155 |
135%
upside
| 1 | -8.9% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $76 |
28%
upside
| 1 | +2.7% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $94 |
9%
downside
| 1 | +39% |
0
%
| 4 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $110 |
17%
upside
| 1 | – |
–
| 3 Feb ‘26 2 months ago |
|